TheFly.com
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
VIRX
Viracta Therapeutics
$
()
VIRX
Viracta Therapeutics' Phase 1b/2 trial of Nana-val advances to second dose
VIRX
6/2/2022 - 08:33am
Viracta Therapeutics reports Q1 EPS (28c), consensus (31c)
VIRX
5/10/2022 - 16:20pm
Viracta Therapeutics to hold a webinar
VIRX
4/27/2022 - 10:01am
Viracta Therapeutics reports Q4 EPS (31c), consensus (43c)
VIRX
3/16/2022 - 08:32am
Viracta Therapeutics options imply 23.2% move in share price post-earnings
VIRX
3/14/2022 - 14:19pm
Palisade Bio adds Robert McRae as SVP, Operations, Strategic Development
PALI
,
VIRX
2/15/2022 - 08:47am
RBC Capital starts Viracta Therapeutics at Outperform, sees 'overlooked' story
VIRX
1/31/2022 - 16:48pm
Viracta Therapeutics initiated with an Outperform at RBC Capital
VIRX
1/31/2022 - 16:43pm
Viracta Therapeutics doses first patient in Phase 1b/2 Nana-val trial
VIRX
1/31/2022 - 08:32am
American Society of Hematology (ASH) to hold annual meeting
ABBV
,
AGIO
,
CLLS
…
12/14/2021 - 04:55am
Viracta Therapeutics presents preclinical Vecabrutinib data at ASH
VIRX
12/13/2021 - 19:21pm
Viracta reports 10.4 month median duration of response in lymphoma study
VIRX
12/13/2021 - 11:34am
American Society of Hematology (ASH) to hold annual meeting
ABBV
,
AGIO
,
CLLS
…
12/13/2021 - 04:55am
American Society of Hematology (ASH) to hold annual meeting
ABBV
,
AGIO
,
CLLS
…
12/12/2021 - 14:45pm
Viracta Therapeutics announces ODD granted by FDA for Nana-val
VIRX
11/29/2021 - 08:08am
dynamic_feed
Breaking News
search
Search
menu
Menu
TheFly.com TheFly.com
